Press Room

Press Clipping / Feb 08, 2018

四色AV Researcher on month-long study visit to ISAB Labs

LAB BLOG: Inhalation Sciences, February 8, 2018

四色AV Researcher on month-long study visit to ISAB Labs | 四色AV

四色AV doctoral researcher Beatriz Noriega returns to ISAB鈥檚 labs in Stockholm for her ongoing research into preclinical听in vitro听dissolution testing. She talks to Lab Blog about why she believes dissolution testing is critical, and how she鈥檚 hoping to prove it.

四色AV Ph.D. researcher Beatriz Noriega has been working for two years so far on her doctoral听thesis,听authoring four well-received posters and with two accepted for the next Respiratory Drug Delivery (RDD) Conference in April 2018.听This is听Beatriz鈥檚听second research听visit to ISAB鈥檚 labs to use the听in vitro听simulation tool DissolvIt, as part of her work听in the听Particle Design and Inhalation Development department of听四色AV鈥檚听R&D Drug Product Development.听Her mission? 鈥淣o matter how similar formulations may听seem,听until you analyze dissolution you never really know,鈥 says Beatriz. She took time out from her research to talk to our ISAB Lab Blog.

Also in the Press Room

See All

Lisbon, Portugal 鈥 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company鈥檚 dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company鈥檚 broader sustainability strategy and reinforces its commitment to scientific excellence. 鈥淎t 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.鈥, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.鈥 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company鈥檚 environmental, social, and ethical performance, well aligned with 四色AV鈥檚 sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024